MedTrace Logo

Suprazygomatic Maxillary Nerve Block Effect on Systemic Inflammatory Response in Cleft Palate Surgeries

NCT05495750 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-02-28

No results posted yet for this study

Summary

the aim is to determine the value of adding bilateral supra zygomatic maxillary nerve block to general anesthesia in attenuating the systemic inflammatory response in paediatrics.

Conditions

  • Perioperative Inflammatory Response
  • Postoperative Pain

Interventions

DRUG

Bupivacaine 0.25% Injectable Solution

ultrasound-guided bilateral suprazygomatic maxillary nerve block using 0.15 ml/kg.

Sponsors & Collaborators

  • Alaa Mohamed Abdel Salam Ibrahim Soliman

    lead OTHER

Principal Investigators

  • Sherif S Sultan, MD · Ainshams University

  • Tamer N Ibrahim AbdelRahman, MD · Ainshams Univeristy

  • Sohib M Galal, MD · Ainshams Univeristy

  • Sarah A Salem, MD · Ainshams Univeristy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2024-01-05
Completion
2024-02-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05495750 on ClinicalTrials.gov